Search Results 1-10 of 11614 for Ibrance
Ibrance. Back to top. Description. Palbociclib is used to treat hormone receptor (HR)-positive, HER-2 negative advanced or metastatic (cancer that has spread) ...
Endocrine resistance is common in patients with breast cancer, and while the drug palbociclib (Ibrance) in combination with endocrine therapy has provided ...
Palbociclib (Ibrance). Ribociclib (Kisqali). Everolimus (Afinitor). Results. You'll meet with your cancer doctor, called an oncologist, regularly for follow ...
Ibrance. Also known as. Palbociclib (oral route) · Ibrexafungerp (oral route) · Ibritumomab (intravenous route) · Ibrutinib (oral route). Ibsrela. Also known as.
... (Ibrance) and endocrine therapy. Other aims are to discover microbiome-based biomarkers of treatment response, to evaluate drug response phenotypes using ...
Fulvestrant injection is used to treat hormone-receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in ...
The purpose of this study is to estimate the best response of enfortumab vedotin treatment for patients with metastatic squamous cell carcinoma of the penis ( ...
This randomized phase II trial studies how well carboplatin and paclitaxel with or without atezolizumab before surgery works in treating patients with newly ...
Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes. It is not yet known whether letrozole is more ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.